Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells

Journal of Nutrition

Volumn 134, Issue 10, 2004, Pages 2509-2516

  Noé, Véronique ^a   Peñuelas, Silvia ^a   Lamuela Raventós, Rosa M ^a   Permanyer, Joan ^a   Ciudad, Carlos J ^a   Izquierdo Pulido, Maria ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antioxidant; cDNA arrays; Cocoa; Epicatechin; Gene expression

Indexed keywords

ANTIOXIDANT; DNA TOPOISOMERASE; EPICATECHIN; FERRITIN; FLAVANOID; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MYELOID LEUKEMIA FACTOR 2; POLYPHENOL DERIVATIVE; PROTEIN FTH1; PROTEIN XRCC1; STAT1 PROTEIN; TOPOISOMERASE 1; UNCLASSIFIED DRUG;

ARTICLE; CACAO; CELL CULTURE; CELL STRAIN CACO 2; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; FTH1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; MAPKK1 GENE; MLF2 GENE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAT1 GENE; TOPOISOMERASE 1 GENE; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING; XRCC1 GENE;

THEOBROMA CACAO;

EID: 4744371522     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2509     Document Type: Article

References (51)

1. Scalbert, A. & Williamson, G. (2000) Dietary intake and bioavaliability of polyphenols. J. Nutr. 130: 2073S-2085S.
2. Geleijnse, J. M., Launer, L. J., Van der Kuip, D. A., Hofman, A. & Witteman, J. C. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am. J. Clin. Nutr. 75: 880-886.
3. Arts, I.C.W., Hollman, P.C.H., Feskens, E.J.M., Bas Bueno de Mesquita, H. & Kromhout, D. (2001) Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am. J. Clin. Nutr. 74: 227-232.
4. Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clint. Nutr. 74: 418-425.
5. Steinberg, F. M., Bearden, M. M. & Keen, C. L. (2003) Cocoa and chocolate flavonoids: implications for cardiovascular health. J. Am. Diet. Assoc. 103: 215-223.
6. Waterhouse, A. L., Shirley, J. R. & Donovan, J. L. (1996) Antioxidants in chocolate. Lancet 348: 834.
7. Arts, I.C.W., van de Putte, B. & Hollman, P.C.H. (2000) Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J. Agric. Food Chem. 48: 1746-1751.
8. Hammerstone, J. F., Lazarus, S. A. & Schmitz, H. H. (2000) Procyanidin content and variation in some commonly consumed foods. J. Nutr. 130: 2086S-2092S.
9. Lamuela-Raventós, R. M., Andrés-Lacueva, C., Permanyer, J. & Izquierdo-Pulido, M. (2001) More antioxidants in cocoa. J. Nutr. 131: 834.
10. Rein, R., Lotito, S., Holt, R. R., Keen, C. L., Schmitz, H. H. & Fraga, C. G. (2000) Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma antioxidant capacity. J. Nutr. 130: 2109S-2114S.
11. Holt, R. R., Lazarus, S. A., Sullards, M. C., Zhu, Q. Y., Schramm, D. D., Hammerstone, J. F., Fraga, C. G., Schmitz, H. H. & Keen, C. L. (2002) Procyanidin dimer B2 [epicatechin- (4beta-8)-explicate] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76: 798-804.
12. Arts, I.C.W., Hollman, P.C.H. & Kromhout, D. (1999) Chocolate as a source of tea flavonoids. Lancet 354: 488.
13. Ministerio de Agricultura, Pesca y Alimentación (2002) La alimentación en España 2002. Ministerio de Agricultura, Pesca y Alimentación, Madrid, Spain.
14. Müller, M. & Kersten, S. (2003) Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4: 315-322.
15. van Ommen, B. & Stierum, R. (2002) Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr. Opin. Biotechnol. 13: 517-521.
16. Andrés-Lacueva, C., Lamuela-Raventós, R. M., Jáuregui, O., Casals, I., Izquierdo-Pulido, M. & Permanyer, J. (2000) An LC method for the analysis of cocoa phenolics. LC-GC Europe 12: 902-905.
17. Swain, T. & Hillis, W. E. (1969) The total phenolic constituents of Prunus domestica. J. Sci. Food Agric. 46: 4292-4296.
18. Artursson, P., Palm, K. & Luthman, K., (2001) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46: 27-43.
19. Salucci, M., Stivala, L. A., Maiani, G., Bugianesi, R. & Vannini, V. (2002) Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br. J. Cancer 86: 1645-1651.
20. Llaverias, G., Noe, V., Peñuelas, S., Vazquez-Carrera, M., Sanchez, R. M., Laguna, J. C., Ciudad, C. J. & Alegret, M. (2004) Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem. Biophys. Res. Commun. 318: 265-274.
21. Noé, V., MacKenzie, S. & Ciudad, C. J. (2003) An intron is required for dihydrofolate reductase protein stability. J. Biol. Chem. 278: 38292-33800.
22. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C. & King, C. R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6: 605-610.
23. Bradford, M. M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
24. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. Rocke, D. M. & Durbin, B. (2001) (2001) A model for measurement error for gene expression analysis. J. Comput. Biol. 8: 557-570.
26. Yamane, Y., Furuichi, M., Song, R., Vani, N. T., Mulcahy, T. Ishikawa, T. & Kuo, M. T. (1998) Expression of multidrug resistance protein/GS-X pump- and g-glutamylcysteine synthetase genes is regulated by oxidative stress. J. Biol. Chem. 273: 31075-31085.
27. Nguyen, H., Zhang, S. & Morris, M. E. (2003) Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J. Pharm. Sci. 92: 250-257.
28. Wortelboer, H. M., Usta, M., van der Velde, A. E., Boersma, M. G., Spenkelink, B., van Zanden, J. J., Rietjens, I. M., van Bladeren, P. J. & Cnubben, N.H.P. (2003) Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem. Res. Toxicol. 16: 1642-1651.
29. Torres, M. & Forman, H. J. (2003) Redox signaling and the MAP kinase pathways. Biofactors 17: 287-296.
30. Kobuchi, H., Roy, S., Sen, C. K., Nguyen, H. G. & Packer, L. (1999) Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol. 277: 403-411.
31. Kong, A.-N.T., Yu, R., Chen, C., Mandlekar, S. & Primiano, T. (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch. Pharm. Res. 23: 1-16.
32. Briviba, K., Pan, L. & Rechkemmer, G. (2002) Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases. J. Nutr. 132: 2814-2818.
33. Yu, R., Jiao, J. J., Duh, J. L., Gudehithlu, K., Tan, T. H. & Kong, A. N. (1997) Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 18: 451-456.
34. Chen, C., Yu, R., Owuor, E. D. & Kong, A. N. (2000) Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 6: 605-612.
35. Miller, L. L., Miller, S. C., Torti, S. V., Tsuji, Y. & Torti, F. M. (1991) Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 88: 4946-4950.
36. Orino, L. K., Lehman, O., Tsuji, Y., Ayaki, H., Torti, S. V. & Torti, F. M. (2001) Ferritin and the response to oxidative stress. Biochem. J. 357: 241-247.
37. Maziere, C., Alimardani, G., Dantin, F., Dubois, F., Conte, M. & Maziere, J. (1999) Oxidized LDL activates STAT1 and STAT3 transcription factors: possible involvement of reactive oxygen species. FEBS (Feb. Eur. Biochem. Soc.) Lett. 448: 49-52.
38. Shirakawa, F., Saito, K., Bonagura, C. A., Galson, D. L., Fenton, M. J., Webb, A. C. & Auron, P. E. (1993) The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13: 1332-1344.
39. Wedel, A., Sukski, G. & Ziegler-Heitbrock, H. W. (1996) CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 8: 335-341.
40. Mao, T. K., Van de Water, J., Keen, C. L., Schmitz, H. H. & Gershwin, M. E. (2002) Effect of cocoa flavanols and their related oligomers on the secretion of interleukin-5 in peripheral blood mononuclear cells. J. Med. Food 5: 17-22.
41. Schramm, D. D., Wang, J. F., Holt, R. R., Ensunsa, J. L, Gonsalves, J. L., Lazarus, S. A., Schmitz, H. H., German, J. B. & Keen, C. L. (2001) Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am. J. Clin. Nutr. 73: 36-40.
42. Mao, T. K., Van de Water, J., Keen, C. L., Schmitz, H. H. & Gershwin, M. E. (2000) Cocoa procyanidins and human cytokine transcription and secretion. J. Clin. Nutr. 130: 2093S-2099S.
43. Sangboni, C., Suzuki, N. & Sakane, T. (1997) Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol. 177: 129-136.
44. Osakabe, N., Sanbongi, C., Yamagishi, M., Takizawa, T. & Osawa, T. (1998) Effects of polyphenol substances derived from Theobroma cacao on gastric mucosal lesion induced by ethanol. Biosci. Biotechnol. Biochem. 62: 1535-1538.
45. Husain, I., Mohler, J. L., Seigler, H. F. & Besterman, J. M. (1994) Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 54: 539-546.
46. Takimoto, C. H., Wright, J. & Arbuck, S. G. (1998) Clinical applications of the camptothecins. Biochim. Biophys. Acta 1400: 107-119.
47. Caldecott, K. W. (2001) Mammalian DNA single-strand break repair: an x-ra(y)ted affair. Bioessays. 23: 447-455.
48. Masson, M., Niedergang, C., Schreiber, V., Muller, S., Ménissier-de Murcia, J. & de Murcia, G. (1998) XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 18: 3563-3571.
49. Kuefer, M. U., Look, A. T., Williams, D. C., Valentine, V., Naeve, C. W., Behm, F. G., Mullersman, J. E., Yoneda-Kato, N., Montgomery, K., et al. (1996) cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia/myeloid leukemia factor 2 (MLF2). Genomics 35: 392-396.
50. Yoneda-Kato, N., Look, A. T., Kirstein, M. N., Valentine, M. B., Raimondi, S. C., Cohen, K. J., Carroll, A. J. & Morris, S. W. (1996) The t (3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12: 265-275.
51. Yoneda-Kato, N., Fukuhara, S. & Kato, J. Y. (1999) Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein. Oncogene 18: 3716-3724.